BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
9/25/2025 11:24:01 AM | Browse: 58 | Download: 38
 |
Received |
|
2025-04-27 03:06 |
|
Peer-Review Started |
|
2025-04-27 08:49 |
 |
To Make the First Decision |
|
|
|
Return for Revision |
|
2025-05-22 11:20 |
|
Revised |
|
2025-06-13 18:50 |
|
Second Decision |
|
2025-08-06 02:36 |
|
Accepted by Journal Editor-in-Chief |
|
|
|
Accepted by Executive Editor-in-Chief |
|
2025-08-06 10:23 |
|
Articles in Press |
|
2025-08-06 10:23 |
|
Publication Fee Transferred |
|
|
|
Edit the Manuscript by Language Editor |
|
|
|
Typeset the Manuscript |
|
2025-09-17 03:08 |
|
Publish the Manuscript Online |
|
2025-09-25 11:24 |
| ISSN |
1948-5182 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2025. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Gastroenterology & Hepatology |
| Manuscript Type |
Letter to the Editor |
| Article Title |
Rifaximin and sarcopenia in cirrhosis: Commentary on a promising but complex relationship
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Mohamed El-Kassas and Khalid AlNaamani |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Mohamed El-Kassas, Professor, Endemic Medicine Department, Faculty of Medicine, Helwan University, Ain Helwan, Cairo 11795, Egypt. m_elkassas@yahoo.com |
| Key Words |
Rifaximin; Sarcopenia; Cirrhosis; Myostatin; Gut-liver-muscle axis; Hyperammonemia; Tumor necrosis factor alpha |
| Core Tip |
The study by Worland et al adds valuable data suggesting that rifaximin-α may improve muscle mass in people with cirrhosis. We highlight plausible mechanisms beyond ammonia reduction, such as cytokine suppression and microbiota modulation. However, concerns regarding resistance and the need for prospective validation merit discussion. |
| Publish Date |
2025-09-25 11:24 |
| Citation |
<p>El-Kassas M, AlNaamani K. Rifaximin and sarcopenia in cirrhosis: Commentary on a promising but complex relationship. <i>World J Hepatol</i> 2025; 17(9): 108951</p> |
| URL |
https://www.wjgnet.com/1948-5182/full/v17/i9/108951.htm |
| DOI |
https://dx.doi.org/10.4254/wjh.v17.i9.108951 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
